Product
IMCgp100
Name
IMCgp100
1 clinical trial
1 drug
1 indication
Indication
Uveal melanomaDrug
tebentafuspClinical trial
A Phase I/II Open-label, Multi-center Study of the Safety and Efficacy of IMCgp100 Using the Intra-patient Escalation Dosing Regimen in Patients With Advanced Uveal MelanomaStatus: Completed, Estimated PCD: 2020-03-20